•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A06764 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          6764
 
                               2025-2026 Regular Sessions
 
                   IN ASSEMBLY
 
                                     March 12, 2025
                                       ___________
 
        Introduced by M. of A. WEPRIN -- read once and referred to the Committee
          on Insurance
 
        AN ACT to amend the insurance law, in relation to reporting requirements
          for pharmacy benefit managers
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Paragraph 1 of subsection (a) of section 2904 of the insur-
     2  ance law, as amended by chapter 128 of the laws of 2022, is  amended  to
     3  read as follows:
     4    (1)  (i)  On or before July first of each year, every pharmacy benefit
     5  manager shall report to the superintendent, in  a  statement  subscribed
     6  and  affirmed  as  true  under  penalties  of  perjury,  the information
     7  requested by the superintendent including, without limitation,
     8    [(i)] (A) any pricing discounts, rebates  of  any  kind,  inflationary
     9  payments, credits, clawbacks, fees, grants, chargebacks, reimbursements,
    10  other   financial  or  other  reimbursements,  incentives,  inducements,
    11  refunds or other benefits received  by  the  pharmacy  benefit  manager;
    12  [and]
    13    [(ii)]  (B)  the  terms and conditions of any contract or arrangement,
    14  including other financial or other  reimbursements  incentives,  induce-
    15  ments  or  refunds  between  the  pharmacy benefit manager and any other
    16  party relating to pharmacy benefit management  services  provided  to  a
    17  health  plan including but not limited to, dispensing fees paid to phar-
    18  macies[.];
    19    (C) the aggregated dollar amount of rebates,  fees,  price  protection
    20  payments  and  any  other payments the pharmacy benefit manager received
    21  from drug manufacturers through rebate contracts;
    22    (D) the portions of the amount in  clause  (C)  of  this  subparagraph
    23  which were:
    24    1. passed on to health plans; or
    25    2. retained by the pharmacy benefit manager; and
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10316-01-5

        A. 6764                             2
 
     1    (E) for each rebate contract in effect during the reporting period:
     2    1. the names of the contracting parties;
     3    2.  the  execution date and the term of the contract, including exten-
     4  sions;
     5    3. the name of the  drugs  and  the  associated  national  drug  codes
     6  covered by the rebate contract, and for each drug:
     7    (I)  a  summary  of  the contract terms regarding formulary placement,
     8  formulary exclusion, or prior authorization requirements or step  edits,
     9  of any drugs considered to compete with each drug;
    10    (II)  a  summary  of  all  terms  requiring or incentivizing volume or
    11  market share for each  drug,  including  base  rebate  amounts,  bundled
    12  rebates  and  incremental  rebates, stated separately, and price conces-
    13  sion, stated separately for each drug; and
    14    (III) the total number of prescriptions filled and units dispensed for
    15  which a rebate, discount, price concession or  other  consideration  was
    16  received by the pharmacy benefit manager for each drug;
    17    4.  the  rebate  percentage and dollar amount retained by the pharmacy
    18  benefit manager for every rebate, discount, price  concession  or  other
    19  consideration under each rebate contract; and
    20    5. the dollar amount of any other compensation paid by a drug manufac-
    21  turer  to a pharmacy benefit manager for services including distribution
    22  management services, data or data  services,  marketing  or  promotional
    23  services,  research  programs,  or  other ancillary services, under each
    24  rebate contract.
    25    (ii) For the purposes of this subsection, the term  "rebate  contract"
    26  means  any agreement entered into by a pharmacy benefit manager with any
    27  drug manufacturer or agent or affiliate  of  a  drug  manufacturer  that
    28  determines  any  rebate,  discount,  administrative  or other fee, price
    29  concession,  or  other  consideration  related  to  the  dispensing   of
    30  prescription drugs for a health plan.
    31    § 2. Severability. If any provision of this act, or any application of
    32  any  provision of this act, is held to be invalid, that shall not affect
    33  the validity or effectiveness of any other provision of this act, or  of
    34  any other application of any provision of this act.
    35    § 3. This act shall take effect on the one hundred eightieth day after
    36  it shall have become a law.
Go to top